France Ureteral Stents Market Size, Share, By Material (Polymer Ureteral Stents and Metallic Ureteral Stents), By Application (Kidney Stones, Kidney Transplantation, Tumors, Urinary Incontinence, and Others), France Ureteral Stents Market Insights, Industry Trend, Forecasts to 2035

France Ureteral Stents Market Size Insights Forecasts to 2035

• France Ureteral Stents Market Size 2024: USD 24.2 Mn
• France Ureteral Stents Market Size 2035:  USD 46.02 Mn
• France Ureteral Stents Market CAGR 2024: 6.02%
• France Ureteral Stents Market Segments: Phase Type and Service

The France Ureteral Stents Market Size refers to the market for medical devices that are used to relieve or facilitate urine flow from the kidneys to the bladder in patients with ureteral obstruction or injury in hospitals and urology centers in France. These stents, which are typically employed in the above-mentioned scenarios, can be additionally utilized in the cases of renal calculi, strictures, tumors, and after urological surgeries to provide effective urinary drainage. Besides these, a few of the most prominent factors leading to the expansion of this market are the increased incidence of urolithiasis (kidney stones) and urinary tract obstructions, the rapid adoption of minimally invasive urological procedures, and the progress in stent design and materials, as well as the elevated demand for better postoperative care and patient comfort.

In France the rising prevalence of urinary tract stones is the primary factor propelling the France Ureteral Stents Market Size. Affected by urolithiasis, approximately 10% of the France population, and renal colic, making up a significant proportion of the emergency visits, in turn, generating strong clinical demand for stenting and related urological care. Market growth is also supported by the increasing use of minimally invasive procedures such as ureteroscopy, technologically advanced endourological instruments, and better postoperative care.

The France government and public health agencies are backing research and innovation in the field of kidney and urinary diseases, which is the basis of the ureteral stents market in general. For instance, the annual research call of Agence de la biomdecine's REIN is a source of funding close to €20,000 per project for research on chronic kidney disease to deepen knowledge and patient care. France, likewise, is a part of the France 2030 biomedical research investment plan that is committing more than €1.2 billion to enhance health research infrastructure and clinical research, which can lead to the improvement of clinical approaches and device use in urology care.

Market Dynamics of the France Ureteral Stents Market:

The France Ureteral Stents Market Size is influenced by the increasing occurrence of urolithiasis (kidney stones) and urinary tract obstructions, which, in turn, escalate the need for efficient urine drainage solutions. The rise of minimally invasive urological procedures, like ureteroscopy and laser lithotripsy, is thereby fostering the use of stents in pre- and postoperative care. Market growth is also supported by technological innovations in the design, material, and biocompatibility of the stents, which help to improve patient comfort and lower the incidence of complications. Additionally, the increasing availability of specialized urology services throughout France is contributing to the expansion of the market.

The France Ureteral Stents Market Size is restricted by the occurrence of complications associated with stents, such as discomfort, infection, encrustation, and the requirement for additional procedures for the removal or replacement of the stent. Besides, expensive devices, inadequate reimbursement for advanced stent technologies, and patients' unwillingness due to the negative impact on the quality of life can also limit the adoption of stents in general, especially in the case of prolonged use.

Future opportunities in the France Ureteral Stents Market Size include the development and subsequent adoption of advanced materials and coatings of stents capable of reducing encrustation, improving biocompatibility, and decreasing patient discomfort. The trend towards minimally invasive and outpatient urology procedures is likely to result in increased demand for novel stenting solutions. Moreover, the use of smart and bioresorbable stents, as well as the growing implementation of digital health tools for post-procedure monitoring and patient follow-up, will contribute to better outcomes and market expansion.

Market Segmentation

The France Ureteral Stents Market share is classified into material and application.

By Material:

The France Ureteral Stents Market Size is divided by material into polymer ureteral stents and metallic ureteral stents. Among these, the polymer ureteral stents segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The polymer ureteral stents segment's dominance is due to their flexibility, better patient comfort, lower cost, ease of placement and removal, and widespread suitability for short- to medium-term urinary drainage in routine urological procedures across France.

By Application:

The France Ureteral Stents Market Size is divided by application into kidney stones, kidney transplantation, tumors, urinary incontinence, and others. Among these, the kidney stones segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The kidney stones segment dominates because of the high prevalence of urolithiasis in France, frequent use of ureteral stents before and after stone removal procedures, and the widespread adoption of minimally invasive treatments such as ureteroscopy and laser lithotripsy.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the France Ureteral Stents Market Size, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Top Key Companies in France Ureteral Stents Market:

• Boston Scientific Corporation
• Cook Medical LLC
• Teleflex Incorporated
• Olympus Corporation
• Coloplast Corp.
• C.R. Bard
• Cook Urological
• Uromedica Pty Ltd
• B. Braun Melsungen AG
• Lumenis Ltd.
• Others

Recent Developments in France Ureteral Stents Market:

• In April 2024, Olympus announced FDA clearance of its RenaFlex single-use flexible ureteroscope system, enhancing access and visualization in urinary tract procedures such as kidney stone management, supporting improved minimally invasive urology care.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the France, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the France Ureteral Stents Market Size based on the below-mentioned segments:

France Ureteral Stents Market, By Material

• Polymer Ureteral Stents
• Metallic Ureteral Stents

France Ureteral Stents Market, By Application

• Kidney Stones
• Kidney Transplantation
• Tumors
• Urinary Incontinence
• Others